Date: 2015-12-07
Type of information: Opening of new premises
Compound:
Company: Addex Therapeutics (Switzerland)
Therapeutic area:
Type agreement: opening of new premises
Action mechanism:
Disease:
Details: * On December 7, 2015, Addex Therapeutics announced that it has moved its R&D operations to the Campus Biotech. This new life sciences center is located at the former Merck Serono site in Geneva. Extending out over 40,000m2, this center welcomes many academic and industrial partners, of which, in particular, teams from EPFL (the Lausanne-based Swiss Federal Institute of Technology), UNIGE (University of Geneva), the University Hospitals of Geneva, the Wyss Centre of bio- and neuro-engineering, the Human Brain Project, the Swiss Institute of bioinformatics, and the HEPIA which is part of the HES-SO (University of Applied Sciences Western Switzerland). This new ecosystem is based on an interdisciplinary scientific approach to stimulating innovation in the area of life sciences. Its main objective is to concentrate on pure science and its transposition into products which will have a direct impact on society and on the world. Campus Biotech was established by a consortium made up of the EPFL, UNIGE, the Bertarelli family and HansJörg Wyss.
Financial terms:
Latest news:
